🔎 Trials Near Me

መነሻ › የኤንዶሜትሪየም ካንሰር › Rhode Island › Providence

በProvidence፣ RI ለየኤንዶሜትሪየም ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየኤንዶሜትሪየም ካንሰር የሚደረጉ 14 ጥናቶች በProvidence እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Women and Infants Hospital, Providence
  • Roger Williams Medical Center, Providence
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05564377

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Women and Infants Hospital, Providence
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05950464

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Rhode Island Hospital, Providence
  • Women and Infants Hospital, Providence
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07198074

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Women and Infants Hospital, Providence
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT05112601

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Women and Infants Hospital, Providence
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT05640999

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Women & Infants Hospital ( Site 5003), Providence
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT06952504

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Women & Infants Hospital of Rhode Island, Providence
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06515613

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Providence
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06989112

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site, Providence
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ21 ኦገስ 2026 · NCT05797168

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Women & Infants Hospital, Providence
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ21 ኦገስ 2026 · NCT05548296

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Women and Infants Hospital of Rhode Island, Providence
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT05579366

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Women & Infants Hospital, Providence
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኖቬም 2025 · NCT05997017

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Women & Infants Hospital, Providence
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኖቬም 2025 · NCT05902988

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, Providence
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

በሌሎች ከተሞች ለየኤንዶሜትሪየም ካንሰር የሚደረጉ ጥናቶች

በProvidence ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።